Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons
This review provides insight into the role of engineered T-cell receptors (TCRs) in immunotherapy. Novel approaches have been developed to boost anticancer immune system, including targeting new antigens, manufacturing new engineered or modified TCRs, and creating a safety switch for endo-suicide ge...
Main Authors: | Qijie Zhao, Yu Jiang, Shixin Xiang, Parham Jabbarzadeh Kaboli, Jing Shen, Yueshui Zhao, Xu Wu, Fukuan Du, Mingxing Li, Chi Hin Cho, Jing Li, Qinglian Wen, Tao Liu, Tao Yi, Zhangang Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.658753/full |
Similar Items
-
Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
by: Shixin Xiang, et al.
Published: (2021-04-01) -
Increased ABCC4 Expression Induced by ERRα Leads to Docetaxel Resistance via Efflux of Docetaxel in Prostate Cancer
by: Houbao Huang, et al.
Published: (2020-08-01) -
m5C RNA Methylation Primarily Affects the ErbB and PI3K–Akt Signaling Pathways in Gastrointestinal Cancer
by: Shixin Xiang, et al.
Published: (2020-12-01) -
Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer
by: Yongshun Ma, et al.
Published: (2021-02-01) -
Conditional reprogramming: next generation cell culture
by: Xiaoxiao Wu, et al.
Published: (2020-08-01)